Targeted photodynamic therapy for challenging forms of prostate cancer

We already know that linking certain types of radioactive agent to specific forms of prostate-specific membrane antigen (PSMA) offers new opportunities for the treatment of challenging cases of prostate cancer. … READ MORE …

New trial of VTP for localized prostate cancer opens at five US centers

A media release from New York University Langone Medical Center, issued yesterday, has announced the initiation of a multi-center, Phase I/II clinical trial of vascular-targeted photodynamic therapy (VTP) in men with localized prostate cancer. … READ MORE …